Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationLeukapheresisGranulocyte Colony-Stimulating FactorAntigens, CD34Transplantation ConditioningTransplantation, HomologousMelphalanBlood Component RemovalHematopoietic Stem CellsCombined Modality TherapyHematologic NeoplasmsCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaThiotepaLymphoma, Non-HodgkinGraft SurvivalStem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseEtoposideTreatment OutcomeCarmustineHematopoiesisMyeloablative AgonistsBusulfanAntineoplastic Agents, AlkylatingStem CellsIfosfamideRemission InductionBlood Cell CountHodgkin DiseaseRecurrenceSalvage TherapyCytarabineVincristinePlatelet CountCytophagocytosisDisease-Free SurvivalBone Marrow PurgingNeoplasmsGranulocytesBlood CellsRecombinant ProteinsWhole-Body IrradiationAmyloidosisTime FactorsRetrospective StudiesTissue DonorsCarboplatinSurvival RateCord Blood Stem Cell TransplantationDoxorubicinTransplantation ChimeraColony-Forming Units AssayCytapheresisLymphomaSurvival AnalysisHistocompatibility TestingLeukemiaCell SeparationLeukocyte CountBone MarrowInfectionLymphoma, T-CellHistocompatibilityBreast NeoplasmsStem Cell FactorFeasibility StudiesGranulocyte-Macrophage Colony-Stimulating FactorImmunomagnetic SeparationBlood Transfusion, AutologousPOEMS SyndromeProspective StudiesFollow-Up StudiesImmunophenotypingBone Marrow CellsLeukemia, Myeloid, AcutePrednisoneImmunosuppressive AgentsAntineoplastic AgentsAntigens, CDBlood DonorsHematologic DiseasesTransplantation, IsogeneicDexamethasoneFlow CytometryCells, CulturedVidarabineLeukocytes, MononuclearPlatelet TransfusionCell DifferentiationCytomegalovirus InfectionsNeoplasm, ResidualFatal OutcomeGraft vs Leukemia EffectCell Count